From Casetext: Smarter Legal Research

Novartis Pharma AG v. Incyte Corp.

United States District Court, S.D. New York
Mar 22, 2022
20 Civ. 400 (GHW)(GWG) (S.D.N.Y. Mar. 22, 2022)

Opinion

20 Civ. 400 (GHW)(GWG)

03-22-2022

NOVARTIS PHARMA AG Plaintiff, v. INCYTE CORPORATION Defendant.


ORDER

GABRIEL W. GORENSTEIN, UNITED STATES MAGISTRATE JUDGE

For the reasons stated today on the record, the applications in Docket # 99, 115 and 116 are granted in part and denied in part. Also, due to the confidential business nature of the material involved, the motions to seal (Docket ## 104, 107, 117, 119) are granted.

SO ORDERED.


Summaries of

Novartis Pharma AG v. Incyte Corp.

United States District Court, S.D. New York
Mar 22, 2022
20 Civ. 400 (GHW)(GWG) (S.D.N.Y. Mar. 22, 2022)
Case details for

Novartis Pharma AG v. Incyte Corp.

Case Details

Full title:NOVARTIS PHARMA AG Plaintiff, v. INCYTE CORPORATION Defendant.

Court:United States District Court, S.D. New York

Date published: Mar 22, 2022

Citations

20 Civ. 400 (GHW)(GWG) (S.D.N.Y. Mar. 22, 2022)